2016 / 04

Next Paper
DOI: 10.24075/brsmu.2016-04-04

METHOD

Dynamic contrast-enhanced MRI in determining histological type of cervical cancer

Tarachkova EV1, Shorikov MA1,2, Panov VO1,2, Kuznetsov VV2, Tyurin IE1,2, Shimanovsky NL3
About authors

1 Department of Roentgenology and Radiology,
Russian Medical Academy of Postgraduate Education, Moscow, Russia

2 N. N. Blokhin Russian Cancer Research Center, Moscow, Russia

3 P. V. Sergeev Molecular Pharmacology and Radiobiology Department, Biomedical Faculty,
Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Elena Tarachkova
ul. Barrikadnaya, d. 2/1, str. 1, Moscow, Russia, 123995; ur.xednay@dikrotcod

Received: 2016-08-10 Accepted: 2016-08-18 Published online: 2017-01-05
|
  1. Bourgioti C, Chatoupis K, Moulopoulos LA. Current imaging strategies for the evaluation of uterine cervical cancer. World J Radiol. 2016; 8 (4): 342–54.
  2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et. al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58 (2): 71–96.
  3. Howlader N, Noone A, Krapcho. M. SEER Cancer Statistics Review, 1975–2010. 2012. Available from: http://seer.cancer.gov/archive/csr/1975_2010/.
  4. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63 (1): 11–30.
  5. Axel EM. Incidence and mortality from malignant tumors of the female reproductive system in Russia. Gynecologic Oncology. 2012; (1): 18–23.
  6. Davydov MI, Kuznetsov VV, Nechushkina MV, editors. Lektsii po onkoginekologii. Moscow: MEDpress-inform; 2009. 432 p.
  7. Cervical Cancer Statistics [Internet]. London: Cancer Research UK. [cited 2016 Aug]. Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/cervix/.
  8. Williams NL, Werner TL, Jarboe EA, Gaffney DK. Adenocarcinoma of the cervix: should we treat it differently? Curr Oncol Rep. 2015; 17 (4): 17.
  9. Tarachkova EV, Streltsova ON, Panov VO, Bazaeva IY, Tyurin IE. Multiparameter magnetic resonance imaging in the diagnosis of cancer of the cervix uteri. Vestnik rentgenologii i radiologii. 2015; (6): 43–55.
  10. Trufanov GE, Panov VO. Rukovodstvo po luchevoy diagnostike v ginekologii. Saint-Petersburg: ELBI-SPb; 2008. 592 p.
  11. Kuang F, Ren J, Zhong Q, Liyuan F, Huan Y, Chen Z. The value of apparent diffusion coefficient in the assessment of cervical cancer. Eur Radiol. 2013; 23 (4): 1050–8.
  12. Nakamura K, Kajitani S, Joja I, Haruma T, Fukushima C, Kusumoto T, et al. The posttreatment mean apparent diffusion coefficient of primary tumor is superior to pretreatment ADCmean of primary tumor as a predictor of prognosis with cervical cancer. Cancer Med. 2013; 2 (4): 519–25.
  13. van Vaals JJ, Brummer ME, Dixon WT, Tuithof HH, Engels H, Nelson RC, et al. Keyhole method for imaging of contrast uptake. J Magn Reson Imaging. 1993; 3 (4): 671–5.
  14. Gutierrez JE, Rosenberg M, Seemann J, Breuer J, Haverstock D, et al. Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study. Magn Reson Insights. 2015; 8: 1–10.
  15. Thomsen HS, Morcos SK, Almén T, Bellin MF, Bertolotto M, Bongartz G, et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2013; 23 (2):307–18.
  16. Koh DM, Thoeny HC, editors. Diffusion-Weighted MR Imaging: Application in The Body. Springer-Verlag Berlin Heidelberg; 2010, p. 7–16.
  17. Giannotti E, Waugh S, Priba L, Davis Z, Crowe E, Vinnicombe S. Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging, Eur J Radiol. 2015; 84 (9): 1729–36.
  18. Malyarenko DI, Ross BD, Chenevert TL. Analysis and correction of gradient nonlinearity bias in ADC measurements. Magn Reson Med. 2014; 71 (3): 1312–23.
  19. Lund KV, Simonsen TG, Hompland T, Kristensen GB, Rofstad EK. Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer. Radiother Oncol. 2015; 115 (3): 379–85.
  20. Campbell JL Jr, Clewell RA, Gentry PR, Andersen ME, Clewell HJ. 3rd Physiologically based pharmacokinetic/toxicokinetic modeling. 2012 Computational Toxicology, Methods in Molecular Biology Series: 439–99.